Zhenming received his Ph.D. in Statistics from the University of Chicago and an M.S. in Mathematics from Peking University. He has built a distinguished career spanning more than 30 years in the pharmaceutical industry and academia, specializing in biostatistics, data management, and clinical drug development. He has held senior leadership positions, including most recently Vice President, Global Head of Biostatistics and Data Management at Daiichi Sankyo and Global Head of Biostatistics in Oncology at Sanofi prior to Daiichi Sankyo. In these roles, he supported strategic business decisions and led global teams responsible for clinical trial design, statistical analysis, and regulatory submissions. His contributions have enabled multiple successful drug approvals in oncology and cardiology, advancing therapies that have improved patient outcomes worldwide. Beyond his industry leadership, Zhenming has authored influential papers in peer-reviewed journals and presented widely at international conferences.